JP2007514732A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007514732A5 JP2007514732A5 JP2006544590A JP2006544590A JP2007514732A5 JP 2007514732 A5 JP2007514732 A5 JP 2007514732A5 JP 2006544590 A JP2006544590 A JP 2006544590A JP 2006544590 A JP2006544590 A JP 2006544590A JP 2007514732 A5 JP2007514732 A5 JP 2007514732A5
- Authority
- JP
- Japan
- Prior art keywords
- carbon
- pharmaceutical composition
- compound
- teo
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53049003P | 2003-12-18 | 2003-12-18 | |
| PCT/IB2004/004163 WO2005060341A2 (en) | 2003-12-18 | 2004-12-15 | Tellurium derivatives for prevention and treatment of neurodegenerative processes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007514732A JP2007514732A (ja) | 2007-06-07 |
| JP2007514732A5 true JP2007514732A5 (enExample) | 2008-01-10 |
Family
ID=34710166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006544590A Pending JP2007514732A (ja) | 2003-12-18 | 2004-12-15 | 神経変性過程の予防及び治療のためのテルル誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7629382B2 (enExample) |
| EP (1) | EP1694313A4 (enExample) |
| JP (1) | JP2007514732A (enExample) |
| AU (1) | AU2004304716B2 (enExample) |
| CA (1) | CA2550459C (enExample) |
| IL (1) | IL176333A0 (enExample) |
| WO (1) | WO2005060341A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1694313A4 (en) | 2003-12-18 | 2010-11-17 | Biomas Ltd | TELLURIUM DERIVATIVES FOR THE PREVENTION AND TREATMENT OF NEURODEEGENERATIVE PROCESSES |
| EP1796660B1 (en) | 2004-09-17 | 2016-11-23 | BioMAS Ltd. | Use of ammonium trichloro(dioxyethylene-o,o')tellurate (as101) for the inhibition of interleukin-1beta-converting enzyme |
| US20080260770A1 (en) * | 2004-09-17 | 2008-10-23 | Biomas Ltd. | Use of Tellurium Compounds as Adjuvants |
| US9216197B2 (en) | 2006-09-11 | 2015-12-22 | Biomas Ltd. | Topical formulations of tellurium-containing compounds |
| CA2705944C (en) * | 2007-11-23 | 2017-10-24 | Biomas Ltd. | Methods and compositions for inhibiting integrins using tellurium-containing compounds |
| US20100321208A1 (en) * | 2009-06-23 | 2010-12-23 | Craig Stephen Etchegoyen | System and Method for Emergency Communications |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3369550A (en) * | 1967-02-17 | 1968-02-20 | Thomas A. Armao | Cryogenic clamps |
| GB1427415A (en) | 1973-09-21 | 1976-03-10 | Armao T A | Cryosurgical instruments |
| US4962207A (en) * | 1985-09-30 | 1990-10-09 | Bar-Ilan University | Organic derivatives of tellurium and selenium |
| US5102908A (en) * | 1985-03-15 | 1992-04-07 | Michael Albeck | Method of treating Acquired Immunedeficiency Syndrome (AIDS) using organic tellurium and selenium derivatives |
| US4761490A (en) * | 1985-03-15 | 1988-08-02 | Bar-Ilan University | Organic derivatives of tellurium and selenium and their use to stimulate cytokine production |
| US5093135A (en) * | 1985-09-30 | 1992-03-03 | Michael Albeck | Compounds for the induction of in vivo and in vitro production of cytokines |
| US4752614A (en) * | 1985-09-30 | 1988-06-21 | Bar-Ilan University | Pharmaceutical compositions of tellerium and selenium compounds for the induction of in vivo and in vitro production of cytokines |
| US4929739A (en) * | 1988-03-24 | 1990-05-29 | Bar-Ilan University | Complexes of tellurium and selenium derivatives |
| DE4007473A1 (de) | 1990-03-09 | 1991-09-12 | Tomsk G Med I | Kryoskalpell |
| US5271925A (en) * | 1990-03-09 | 1993-12-21 | Benjamin Sredni | Method for protecting against the effects of radiation which is based on the administration of a selenium or tellurium based compound |
| SE9200502D0 (sv) * | 1992-02-20 | 1992-02-20 | Astra Ab | Novel antioxidants |
| US5262149A (en) * | 1992-08-13 | 1993-11-16 | Benjamin Sredni | Method of treating or preventing alopecia |
| FR2717824B1 (fr) * | 1994-03-25 | 1996-04-26 | Rhone Poulenc Rorer Sa | Virus recombinants, préparation et utilisation en thérapie génique. |
| WO1996006618A1 (en) * | 1994-09-01 | 1996-03-07 | Pharmacia & Upjohn Company | Cosolvent parenteral formulation of tirilazad |
| US5576347A (en) * | 1994-11-14 | 1996-11-19 | Sredni; Benjamin | Method of treating gastric ulcers |
| US5654328A (en) * | 1994-12-15 | 1997-08-05 | Sredni; Benjamin | Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds |
| WO1996018401A1 (en) | 1994-12-15 | 1996-06-20 | Baker Norton Pharmaceuticals, Inc. | Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound |
| US6428534B1 (en) * | 1999-02-24 | 2002-08-06 | Cryovascular Systems, Inc. | Cryogenic angioplasty catheter |
| CA2369095C (en) * | 1999-04-08 | 2006-07-25 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders |
| WO2001098325A1 (en) | 2000-06-19 | 2001-12-27 | University Of Southern California | Methods for treating and preventing alopecia |
| US6747008B1 (en) * | 2000-06-19 | 2004-06-08 | University Of Southern California | Methods for treating and preventing alopecia |
| US20030148970A1 (en) * | 2001-01-12 | 2003-08-07 | Besterman Jeffrey M. | Methods for specifically inhibiting histone deacetylase-4 |
| US6472381B1 (en) * | 2001-10-12 | 2002-10-29 | Biomas Inc. | Method of treating psoriasis |
| IL146694A (en) * | 2001-11-22 | 2010-12-30 | Biomas Ltd | Use of an aqueous solution containing a biologically active complex of tellurium dioxide for manufacturing a medicament |
| AU2004246895A1 (en) * | 2003-06-12 | 2004-12-23 | Biomas Ltd. | Methods of treating obesity and related disorders using tellurium and selenium compounds |
| EP1694313A4 (en) | 2003-12-18 | 2010-11-17 | Biomas Ltd | TELLURIUM DERIVATIVES FOR THE PREVENTION AND TREATMENT OF NEURODEEGENERATIVE PROCESSES |
| EP1796660B1 (en) | 2004-09-17 | 2016-11-23 | BioMAS Ltd. | Use of ammonium trichloro(dioxyethylene-o,o')tellurate (as101) for the inhibition of interleukin-1beta-converting enzyme |
| US20080260770A1 (en) * | 2004-09-17 | 2008-10-23 | Biomas Ltd. | Use of Tellurium Compounds as Adjuvants |
-
2004
- 2004-12-15 EP EP04801399A patent/EP1694313A4/en not_active Withdrawn
- 2004-12-15 CA CA002550459A patent/CA2550459C/en not_active Expired - Fee Related
- 2004-12-15 WO PCT/IB2004/004163 patent/WO2005060341A2/en not_active Ceased
- 2004-12-15 JP JP2006544590A patent/JP2007514732A/ja active Pending
- 2004-12-15 AU AU2004304716A patent/AU2004304716B2/en not_active Ceased
-
2005
- 2005-09-15 US US11/226,374 patent/US7629382B2/en not_active Expired - Fee Related
-
2006
- 2006-06-15 IL IL176333A patent/IL176333A0/en not_active IP Right Cessation
-
2009
- 2009-11-12 US US12/591,175 patent/US20100062081A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006182786A5 (enExample) | ||
| JP2006523216A5 (enExample) | ||
| JP2007517807A5 (enExample) | ||
| JP2013540114A5 (enExample) | ||
| JP2014518546A5 (enExample) | ||
| JP2009504748A5 (enExample) | ||
| JP2004534850A5 (enExample) | ||
| JP2004516314A5 (enExample) | ||
| JP2006500370A5 (enExample) | ||
| JP2005506352A5 (enExample) | ||
| JP2005500357A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| TW200607807A (en) | Macrocyclic beta-secretase inhibitors | |
| JP2016534063A5 (enExample) | ||
| JP2006507220A5 (enExample) | ||
| EP2228064A3 (en) | Pharmaceutical composition containing glycopyrrolate and a beta2 adrenoceptor agonist | |
| JP2006515866A5 (enExample) | ||
| JP2013514980A5 (enExample) | ||
| EA200300424A1 (ru) | Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов | |
| JP2011505356A5 (enExample) | ||
| JP2002527474A5 (ja) | 躁病および双極性障害の治療のための医薬 | |
| JP2005536503A5 (enExample) | ||
| JP2008517913A5 (enExample) | ||
| JP2010505865A5 (enExample) | ||
| JP2008513510A5 (enExample) |